These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1953887

  • 1. Epidural use of methylprednisolone acetate (Depo-Medrol).
    Maxwell DC.
    Med J Aust; 1991 Jul 15; 155(2):134. PubMed ID: 1953887
    [No Abstract] [Full Text] [Related]

  • 2. Intrathecal and epidural/extradural injection of Depo Medrol.
    Jacobs D.
    Med J Aust; 1981 Sep 19; 2(6):301. PubMed ID: 6895401
    [No Abstract] [Full Text] [Related]

  • 3. Epidural Depo-Medrol revisited.
    Sekel R.
    Med J Aust; 1984 Nov 10; 141(10):688. PubMed ID: 6238228
    [No Abstract] [Full Text] [Related]

  • 4. Re: Depo-medrol and facet joint injections.
    Tress B, Lau L.
    Australas Radiol; 1991 Aug 10; 35(3):291. PubMed ID: 1837212
    [No Abstract] [Full Text] [Related]

  • 5. Dangers from methylprednisolone acetate therapy by intraspinal injection.
    Nelson DA.
    Arch Neurol; 1988 Jul 10; 45(7):804-6. PubMed ID: 3291836
    [Abstract] [Full Text] [Related]

  • 6. Epidural use of methylprednisolone acetate (Depo-Medrol).
    Med J Aust; 1991 Jun 17; 154(12):854. PubMed ID: 2041521
    [No Abstract] [Full Text] [Related]

  • 7. Depo-Medrol and myelographic arachnoiditis.
    Med J Aust; 1991 Sep 16; 155(6):421-2. PubMed ID: 1921799
    [No Abstract] [Full Text] [Related]

  • 8. Intra-arterial injection in the rat brain: evaluation of steroids used for transforaminal epidurals.
    Dawley JD, Moeller-Bertram T, Wallace MS, Patel PM.
    Spine (Phila Pa 1976); 2009 Jul 15; 34(16):1638-43. PubMed ID: 19770605
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of lumbar nerve-root pain by intrathecal and epidural injections of depot methylprednisolone acetate.
    Ryan MD, Taylor TK.
    Med J Aust; 1981 Nov 14; 2(10):532-4. PubMed ID: 7033742
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Analysis of the effectiveness of treating severe cases of sciatica of radicular origin by intrathecal administration of Depo-Medrol].
    Niesyty M, Moskal J.
    Wiad Lek; 1989 Dec 01; 41(23):1575-8. PubMed ID: 2669351
    [No Abstract] [Full Text] [Related]

  • 14. Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces.
    Abel R, Nelson DA, Bernat JL.
    Del Med J; 1977 Jun 01; 49(6):331-43. PubMed ID: 577483
    [No Abstract] [Full Text] [Related]

  • 15. Water-soluble contrast myelography using meglumine iothalamate (Conray) with methylprednisolone acetate (Depo-Medrol).
    Davis FM, Llewellyn RC, Kirgis HD.
    Radiology; 1968 Apr 01; 90(4):705-10. PubMed ID: 4966628
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.
    Schlatter J, Nguyen D, Zamy M, Kabiche S, Fontan JE, Cisternino S.
    Eur Spine J; 2019 Jan 01; 28(1):21-30. PubMed ID: 29151132
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Calcification and ossification of the spinal arachnoid after intrathecal administration of Depo-Medrol.
    Carta F, Canu C, Datti R, Guiducci G, Pisani R, Silvestro C.
    Zentralbl Neurochir; 1987 Jan 01; 48(3):256-61. PubMed ID: 3124393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.